SPDR S&P Pharmaceuticals ETF (XPH)

NYSEARCA: XPH · Real-Time Price · USD
46.00
-0.41 (-0.88%)
Oct 31, 2024, 4:00 PM EDT - Market closed
-0.88%
Assets $157.63M
Expense Ratio 0.35%
PE Ratio 16.61
Shares Out 3.40M
Dividend (ttm) $0.70
Dividend Yield 1.50%
Ex-Dividend Date Sep 23, 2024
Payout Ratio 25.13%
1-Year Return +29.61%
Volume 12,381
Open 46.08
Previous Close 46.41
Day's Range 45.74 - 46.29
52-Week Low 34.67
52-Week High 47.41
Beta 0.75
Holdings 47
Inception Date Jun 19, 2006

About XPH

Fund Home Page

The SPDR S&P Pharmaceuticals ETF (XPH) is an exchange-traded fund that is based on the S&P Pharmaceuticals Select Industry index. The fund tracks an equal-weighted index of US pharmaceutical companies. XPH was launched on Jun 19, 2006 and is issued by State Street.

Asset Class Equity
Category Health
Region North America
Stock Exchange NYSEARCA
Ticker Symbol XPH
ETF Provider State Street
Index Tracked S&P Pharmaceuticals Select Industry

Top 10 Holdings

36.64% of assets
Name Symbol Weight
Corcept Therapeutics Incorporated CORT 4.24%
Longboard Pharmaceuticals, Inc. LBPH 4.11%
Intra-Cellular Therapies, Inc. ITCI 3.90%
Bristol-Myers Squibb Company BMY 3.69%
Jazz Pharmaceuticals plc JAZZ 3.58%
Viatris Inc. VTRS 3.51%
Edgewise Therapeutics, Inc. EWTX 3.46%
Catalent, Inc. CTLT 3.41%
Royalty Pharma plc RPRX 3.38%
Pfizer Inc. PFE 3.36%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Sep 23, 2024 $0.19471 Sep 25, 2024
Jun 24, 2024 $0.15573 Jun 26, 2024
Mar 18, 2024 $0.17298 Mar 21, 2024
Dec 18, 2023 $0.17437 Dec 21, 2023
Sep 18, 2023 $0.1201 Sep 21, 2023
Jun 20, 2023 $0.12354 Jun 23, 2023
Full Dividend History

News

XPH: A More Balanced Way To Get Exposure To Pharmaceuticals

The SPDR S&P Pharmaceuticals ETF offers broad-based exposure to the U.S. pharmaceuticals sector, making it a good option for investing in the industry. XPH tracks the performance of the S&P Pharmaceut...

7 months ago - Seeking Alpha

XPH: Non-Diversified U.S.-Based Large-Cap Pharma ETF Isn't Very Attractive

XPH's consistent low yield and poor price growth (mostly negative) over both short-run as well as over long-run should be disheartening for investors. Expiration of a large number of patents within 20...

1 year ago - Seeking Alpha

XPH: Revenue Challenges Ahead For U.S. Pharmaceuticals

XPH gives you exposure to a broad-based cut of the US Pharmaceuticals sector. Patent expirations are a major headwind affecting many companies in the industry.

1 year ago - Seeking Alpha

The Fall Of SVB: What It Means For Healthcare Startups

How SVB's collapse is impacting healthcare startups. Pfizer to buy Seagen for $43B.

Other symbols: BBCBBHFBTIBBIHEIHFIHI
1 year ago - Seeking Alpha

Will 2023 be the year that pharma M&A makes a comeback?

A handful of acquisitions this week point to a more deal-friendly year for biopharma and biotech companies, though none has generated the kind of excitement seen in years past.

Other symbols: XBI
1 year ago - Market Watch

Can Health Care Stocks Outperform Again In 2023?

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

1 year ago - Seeking Alpha

XPH: U.S. Pharmaceuticals Stocks Are Probably Fairly Valued, Cyclically Unattractive

XPH invests in U.S. pharmaceuticals stocks. The fund is concentrated in 44 holdings.

2 years ago - Seeking Alpha

Final Trades: Pharma, Chevron, Uber & more

The "Halftime Report" traders give their top picks to watch for the second half.

Other symbols: CVXUBERRSP
2 years ago - CNBC Television

What The Inflation Reduction Act Means For Drug Prices

The recently enacted Inflation Reduction Act looks to rein in prescription drug prices and could impact the pharma industry's long-term financial performance. The legislation caps out-of-pocket costs ...

Other symbols: BBCBBHIBBIHEIHFIHIIYH
2 years ago - Seeking Alpha

Get ready for more merger mania in pharma sector the rest of the year

Pfizer Inc.'s PFE, +0.24% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, +0.02% is the latest sign that cash-flush drug makers are ready to jump back into dealmaking.

Other symbols: AMGNMRKPFE
2 years ago - Market Watch

Pharma market investments: How ETFs help you dabble in the sector at a modest price

Some health care sector ETFs have exposure to companies like Johnson & Johnson, Pfizer, UnitedHealth

Other symbols: VHTXLV
2 years ago - Fox Business

Pharma In Transition: Context And Opportunities

The pending separation of consumer care businesses by pharmaceutical companies is understandable and may offer investment opportunities.

2 years ago - Seeking Alpha

Dark Clouds On The Horizon For Big Pharma

According to the most recent healthcare report from the OECD, prescribed medicines here in the United States cost $1025.60 per capita, where the average per capita spending in the developed countries ...

3 years ago - Seeking Alpha

Biotech Innovations Remain At Forefront

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r...

3 years ago - Seeking Alpha

3 Pharmaceutical ETFs That Could Be Due For A Rebound

These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of buyers who have gathered around the same price level.

Other symbols: PILL
3 years ago - Benzinga

Moving Beyond COVID In Biopharma

Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,...

3 years ago - Seeking Alpha

Healthcare: A Wide Choice Of Large And Well-Established Companies

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets...

4 years ago - Seeking Alpha

Best Pharmaceutical ETFs for Q1 2021

The best pharmaceutical ETFs for Q1 2021 are KURE, XPH, and IHE.

Other symbols: IHEKURE
4 years ago - Investopedia

Pharma Stocks Poised to Move Higher

Nearby support on the charts suggests that the pharmaceuticals sector could be one to watch over the last few months of 2020.

Other symbols: JAZZZTS
4 years ago - Investopedia

President Trump signs executive orders aimed at lowering drug prices

CNBC's Meg Tirrell reports President Trump has signed four executive orders aimed at lowering drug prices. They include the U.S. allowing importation of prescription drugs from Canada and other countr...

Other symbols: CICVSUNHXBI
4 years ago - CNBC Television

Trump announces series of executive orders aimed at lowering drug costs

President Donald Trump on Friday signed four executive orders aimed at lowering the high cost of prescription drugs in the United States in what would make sweeping changes to the prescription drug ma...

4 years ago - CNBC

Where this top-rated financial advisor is finding opportunities in the market now

Hightower Treasury Partners CIO Richard Saperstein outlines the areas of the market where he currently sees opportunity.

Other symbols: BACLXDISJNJKMBMDTPFE
4 years ago - CNBC Television

What does the investment committee recommend in health care? #AskHalftime

The "Halftime Report" traders answer viewer questions in #AskHalftime.

Other symbols: ADCCCIIYRMDTMRKPFEXLV
5 years ago - CNBC Television

Mizuho: Smaller companies are leading the way in developing vaccines for infectious diseases

Mara Goldstein of Mizuho discusses the difficulty of developing a vaccine quickly during a virus outbreak, and which large and smaller biotech and drug companies investors should be focused on.

5 years ago - CNBC Television

The Trouble With Pharma

The Trouble With Pharma

5 years ago - Seeking Alpha